How Long Does Ozempic Stay in Your System After Stopping?

Ozempic (semaglutide) has a half-life of approximately seven days, which means most of the drug clears your system within four to five weeks after your last injection — not days, and not months. That timeline has real consequences for anyone planning surgery, pregnancy, or a medication switch.

The Half-Life Math: What "Five Weeks" Actually Means

Semaglutide's unusually long half-life is engineered, not accidental. The molecule is modified with a fatty acid chain that binds tightly to albumin in the bloodstream, slowing both enzymatic breakdown and renal clearance [4]. The result: a drug that supports once-weekly dosing but lingers well after you stop.

The arithmetic follows standard first-order kinetics. Each week after your final dose, plasma concentration drops by roughly half [6]:

• Week 1: ~50% remaining
• Week 2: ~25%
• Week 3: ~12.5%
• Week 4: ~6.25%
• Week 5: ~3%

At five half-lives — approximately 35 days — about 97% of semaglutide has been eliminated [1][4]. Small residual amounts may be detectable slightly beyond that window, but clinically meaningful concentrations are gone within five to six weeks for most adults [6][16].

Because the drug accumulates over four to five weeks of weekly dosing before reaching steady state, the total body burden at the time you stop is the sum of recent doses — but that doesn't change the half-life. The clearance clock still runs at one week per cycle regardless of your maintenance dose (0.5 mg, 1 mg, or 2.4 mg as Wegovy) [4].

If you're evaluating whether semaglutide or tirzepatide (Mounjaro/Zepbound) fits your situation better, our tirzepatide vs. semaglutide comparison for 2026 covers the pharmacokinetic and efficacy differences side by side.

Why the Washout Window Matters Clinically

Pregnancy. Semaglutide is contraindicated during pregnancy. Because fetal exposure risk doesn't zero out the moment you inject your last dose, Ozempic and Wegovy labels recommend stopping the drug at least two months before attempting conception — a window that covers the five-to-six-week clearance period plus a safety margin [1][16].

Surgery and anesthesia. Semaglutide slows gastric emptying, which can leave residual stomach contents even after standard pre-op fasting, raising aspiration risk during induction. Most anesthesiology protocols now recommend pausing weekly GLP-1 agents for at least one week before elective procedures — though one week reduces, rather than eliminates, drug levels given the seven-day half-life [4][6].

Switching agents. If you're transitioning from Ozempic to a different GLP-1, clinicians generally wait at least seven days before initiating the new drug to avoid overlapping pharmacodynamic effects, particularly nausea and hypoglycemia risk [6].

If you're managing a transition or starting a new protocol, Marek Health offers supervised GLP-1 and weight-management programs where clinicians can time those switches appropriately.

Weight Regain After Stopping: The Drug Leaves, But the Biology Stays

Clearing semaglutide in five weeks and sustaining its weight-loss benefits are two entirely different things. The STEP-1 trial, published in NEJM, showed mean weight loss of 14.9% at 68 weeks with semaglutide 2.4 mg versus 2.4% with placebo [3][5]. The STEP-4 extension then demonstrated the cost of stopping: participants who discontinued after reaching steady-state weight regained roughly two-thirds of their prior loss within one year [3].

A broader 2026 meta-analysis reported that patients lost an average of ~33 pounds on GLP-1 agonists but regained approximately 22 pounds within 12 months of stopping — with weight returning to near-baseline by around 17 months, and at a rate roughly four times faster than after diet-and-exercise-only interventions [3].

This is not a pharmacokinetic story. The drug is gone in five weeks; the weight returns over 12 to 18 months. What drives regain is the underlying biology of obesity — the neuroendocrine hunger signals and metabolic adaptation that semaglutide was suppressing. Obesity is a chronic disease, and the STEP program evidence consistently supports treating it as one. For context on how compounded alternatives compare in real-world use, see our compounded semaglutide evidence review.

Clinicians and patients weighing long-term strategy — including whether to restart, switch to tirzepatide, or combine pharmacotherapy with structured lifestyle support — can find vetted providers through our weight management treatment hub.

---

Frequently asked questions

How long does Ozempic stay in your system after stopping?

Ozempic stays in your system for approximately four to five weeks after your last injection, based on its seven-day elimination half-life. After five half-lives (roughly 35 days), about 97% of semaglutide has been cleared from the bloodstream [1][4]. Trace amounts may remain slightly beyond that window, but clinically significant concentrations are generally gone within five to six weeks [6].

Will stopping Ozempic cause immediate weight gain?

Weight regain after stopping Ozempic is real but not immediate. The drug clears in about five weeks, but most weight regain unfolds over 12 to 18 months — driven by the return of appetite-regulating hormones and metabolic adaptation, not residual drug levels [3]. The STEP-1 extension data showed two-thirds of lost weight returning within one year of discontinuation, which underscores that semaglutide manages obesity chronically rather than curing it.

How long should you stop Ozempic before surgery?

Most anesthesiology guidelines recommend pausing weekly semaglutide for at least one